Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP7 | O15540 | 1/20 | 0.36 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | G6PC1 | P35575 | 1/20 | 0.32 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | METAP2 | P50579 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4454309 | 0.94 | CYP3A4 (0.35) | FABP7FABP5CYP3A4TDP1 | |
| SCHEMBL4458092 | 0.89 | CYP3A4 (0.38) | CYP3A4TDP1 | |
| SCHEMBL1726166 | 0.83 | FABP7 (0.36) | FABP7FABP5IDO1CYP3A4NPSR1 | |
| SCHEMBL4451111 | 0.77 | CYP3A4 (0.35) | FABP7FABP5CYP3A4TDP1 | |
| SCHEMBL5599006 | 0.74 | HRH1 (0.38) | CYP3A4NPSR1FAAHMGLLCYP2C9 | |
| SCHEMBL5598756 | 0.72 | ROCK2 (0.30) | — | |
| Benzene SCHEMBL11312352 | 0.72 | CA1 (0.32) | FABP7FABP5FAAHMGLL | |
| SCHEMBL1726180 | 0.72 | RAB9A (0.38) | FABP7FABP5IDO1FAAHMGLL | |
| SCHEMBL1726398 | 0.72 | RAB9A (0.38) | FABP7FABP5IDO1FAAHMGLL | |
| SCHEMBL4457992 | 0.71 | CYP3A4 (0.38) | CYP3A4TDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4130590-A | FROM CONJUGATED DIENES AND AMMONIA OR AN AMINE, PALLADIUM COMPOUND-PHOSPHONITE CATALYST | MONSANTO COMPANY (US) | 1978-12-19 | — | — | US | claimed |
| CN-102341175-A | Selective hydrogenation catalyst and methods of making and using same | CHEVRON PHILLIPS CHEMICAL CO | 2012-02-01 | — | — | CN | disclosed |
| EP-1411086-B1 | THERMOPLASTIC POLYMER COMPOSITION | KURARAY CO (JP) | 2010-09-15 | — | — | EP | disclosed |
| US-7138447-B2 | Thermoplastic polymer composition | KURARAY CO., LTD. (JP) | 2006-11-21 | — | — | US | disclosed |
| US-20040176525-A1 | Thermoplastic polymer composition | KURARAY CO., LTD. (JP) | 2004-09-09 | — | — | US | disclosed |
| US-6784226-B2 | COMPOUNDING STYRENIC RESIN WITH GREATER THAN 2 WT % WATER AND ANTIOXIDANT PREPARED BY BLENDING ORGANIC PHOSPHITE OR PHOSPHONITE WITH ACID-BINDING METAL SALT TREATED WITH SURFACE CONDITIONING AGENT | CHI MEI CORPORATION (TW) | 2004-08-31 | — | — | US | disclosed |
| EP-1411086-A1 | THERMOPLASTIC POLYMER COMPOSITION | Kuraray Co., Ltd. (JP) | 2004-04-21 | — | — | EP | disclosed |
| US-20030114559-A1 | Process for producing a styrenic resin composition | CHI MEI CORPORATION | 2003-06-19 | — | — | US | disclosed |
| US-20020002222-A1 | PHOSPHORUS-CONTAINING ANTIOXIDANT STABILIZED AGAINST HYDROLYSIS | CHI MEI CORPORATION (TW) | 2002-01-03 | — | — | US | disclosed |
| US-4305839-A | PHOSPHITES AND PHOSPHONITES FOR COLOR STABILITY | CARSTAB CORPORATION (US) | 1981-12-15 | — | — | US | disclosed |
| US-4130590-A | FROM CONJUGATED DIENES AND AMMONIA OR AN AMINE, PALLADIUM COMPOUND-PHOSPHONITE CATALYST | MONSANTO COMPANY (US) | 1978-12-19 | — | — | US | disclosed |
| US-4100194-A | REACTIONNOF CONJUGATED DIENES WITH AMMONIA AND AMINES IN HYDROXYLIC SOLVENT | MONSANTO COMPANY (US) | 1978-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020002222-A1 | PHOSPHORUS-CONTAINING ANTIOXIDANT STABILIZED AGAINST HYDROLYSIS | LPO, GPX4, GPX1 | FABP7 906/4885FABP5 458/4885IDO1 1559/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.